As usual, Li Liuyi finished the ward rounds, reviewed the medical orders, took off his work clothes in a hurry, and left the Department of Critical Care Medicine.
It has become a habit for him to go to the laboratory and work until night.
The critical care medicine department he leads does not require him to stay in the department for a long time. There are only three situations where he will stay in the department.
First, he is usually in the department during morning rounds every day. He will check all the difficult-to-rescue patients.
The number of beds in the Department of Critical Care Medicine under his leadership has increased to more than 300, ranking first in number in the capital, and perhaps in the country as well.
There are as many as 20 professor-level doctors in his department, almost 15 to 1, and they are super powerful.
Even for advanced training students, the professional title must be deputy director with more than 3 years of experience before they can apply for advanced training. There are also strict examinations when entering.
Therefore, there is no need for Li Liuyi to stay in the ward all the time.
The second situation is that the department organizes a general consultation. The consultation is divided into intra-department consultation and in-hospital consultation, and he will participate in both.
The third situation is a large-scale rescue, and he will be temporarily invited back.
Today, he hurried into the laboratory.
His 6.0 version of the emergency medicine has made new progress. After using it on two patients, Li Liuyi's confidence increased sharply, and the efficacy was greatly improved compared to the 4.0 version.
Although there is no statistical data, based on experience and feeling, once this medicine is used, the effect is immediate.
Li Liuyi is very excited.
He plans to speed up the experiment, and clinical and animal experiments will be carried out almost at the same time.
He has an advantage. Most of his patients are willing to accept new drugs, or experimental drugs, which is a gamble on their lives.
These two clinical trials were used when the patients were in extreme danger, and they miraculously survived.
It has been a while since the people who annoyed him did not come again. Li Liuyi was happy. He estimated that the people who bought the patents might have given up.
Li Liuyi is glad that he did not give in. Otherwise, where would version 6.0 come from?
Li Liuyi is more inclined to believe that the 6.0 version of the first aid medicine is probably close to the ultimate goal. This medicine can be comparable to Su Yajuan's Purple Snow Pill and Longhu Powder.
You must know that Zixuedan and Longhusan are expensive drugs that cost hundreds of thousands per dose, and are simply impossible to promote clinically.
Li Liuyi has only one goal, which is to be widely used in clinical practice and even ordinary people can afford it.
It is a basic requirement to be included in the medical insurance directory.
Li Liuyi's assistant has been able to extract the active ingredients on a large scale, which paves the way for large-scale clinical popularization in the future.
Li Liuyi came to see this extract today.
They need to analyze the purity and test whether there are any side effects and toxicity.
Extracting active ingredients and removing impurities is difficult, but it is not the key.
The key problem has been solved. The efficacy is the most critical. The preliminary conclusions are very exciting. The 6.0 version of the new drug is much more effective than the 4.0 version. Compared with the 3.0 version, it is simply a dimensionality reduction blow.
p>
"I shouldn't apply for the grand prize in version 3.0. Only version 6.0 is eligible." Li Liuyi beamed.
"Teacher, I think version 6.0 can be officially used in clinical practice. Don't wait any longer. In the future, there may not be version 7.0."
Li Liuyi’s experimental assistants are not his students, but they are all accustomed to calling him teacher.
"Well, you're right. With version 6.0, we entered clinical trials ahead of schedule. After that, we only made some fine-tuning based on version 6.0 and were not in a hurry to develop the next generation. Because, to be honest, version 6.0 is basically perfect.
"For the first time, Li Liuyi had the desire to rest.
"Yes, teacher, for the next generation, we can not rush into research and focus on improving version 6.0. I also think it may be the ultimate version."
Li Liuyi smiled.
He is in a particularly good mood.
"Teacher, this is the latest extracted concentrated medicinal liquid." The assistant took out a 10 ml bottle of golden yellow liquid from the storage tank, "According to the ratio of 1:10, I am going to encapsulate it in 100 glass amps."
They have a small dispensing machine that can complete the dispensing very quickly. It is fully automatic.
Li Liuyi walked out of the laboratory carrying a box, which contained 100 bottles of "resuscitation fluid", the 6.0 version of the first aid medicine, which can be used to rescue dozens of people.
He must come to the laboratory to get it in person.
Then return to the Department of Critical Care Medicine.
Today, he plans to use this emergency medicine on 10 patients, temporarily named it "resuscitation fluid." These 10 patients have been strictly screened. They are all deep coma patients and there is a high probability that they will not wake up in the short term.
This experiment was very violent. We did not follow the routine and directly selected the severely ill patients. Once they woke up, there was no need to do the control group.
Of course, the final experiment requires a control group.
Li Liuyi is not here to write a paper. He wants to see the real situation. He can judge whether it has any effect.
Writing a paper requires statistical data and double-blind control. That is strict scientific research.
As for looking at the real situation, Li Liuyi himself does not need to make it so complicated. He can tell at a glance whether the medicine is effective or not.
Last time, he had used it on two patients, and it was effective, very effective.
However, it is small data after all, just two, and the number of specimens is too small.
The minimum number of statistics is 30. Two patients can’t even convince themselves.
Today, he arranged for 10 patients, and he carefully selected 10 very high-quality patients. Six of them had cerebral hemorrhage, deep coma, acute stage, and heavy bleeding. Although hematoma puncture was performed, they did not survive.
During the edema stage and coma, it stands to reason that you will not wake up.
Another person was poisoned by carbon monoxide and was in a coma for more than seven days. It was considered a severe poisoning and it is still unknown whether he will wake up.
There are also 3 cases: 1 case of craniocerebral trauma, 1 case of cardiopulmonary resuscitation for myocardial infarction, and 1 case of cardiopulmonary resuscitation for myocarditis.
These 10 patients, even their families, had given up. When Li Liuyi provided them with a new drug, they quickly signed and agreed to bear all the consequences.
In their words, the consequences of new drugs are, at worst, death.
It was already 9 minutes and 9 minutes dead.
Li Liuyi drove his car and arrived at the building of the Department of Critical Care Medicine in only 15 minutes. His students helped him open the door.
"The 16-bed bed is no longer working, and the blood pressure is only 40/20mmHg." His student said.
"Well, just use the resuscitation fluid." Li Liuyi picked up the medicine box and quickly entered the elevator.
Bed 16 is also one of the subjects of today's experiment. He is a patient with craniocerebral injury. He has suffered extensive injuries for 7 days. His condition is very unstable and he has undergone major rescue operations 4 times.
He used version 3.0 of the medicinal solution several times, and perhaps it was this medicinal solution that saved him.
"The breathing and heartbeat stopped." Li Liuyi entered the ward, and the rescue doctor reported to him.
"Prepare the resuscitation fluid!" Li Liuyi handed 100 tubes of the solution to the head nurse.
This chapter has been completed!